KIT and cancer: Other cancers have been reported in carriers of germline KIT (gKIT) variants, although whether these cancers are attributable to the underlying genotype is unclear.10 Furthermore, a higher incidence of second malignancy has also been reported in patients with sporadic GISTs compared with the general population.18,19